Medical methods of early abortion in developing countries. Consensus statement. The Population Council
- PMID: 9883380
- DOI: 10.1016/s0010-7824(98)00109-7
Medical methods of early abortion in developing countries. Consensus statement. The Population Council
Abstract
PIP: Researchers, health care providers, women's health advocates, donors, and representatives of ministries of health convened in Bellagio, Italy, in July 1998, to assess the potential of medical methods of early pregnancy termination to improve the reproductive health of women in developing countries. Consensus was reached that a mifepristone-prostaglandin (e.g., misoprostol) regimen can be delivered in a manner that is safe, effective, and acceptable in developing country settings. As long as back-up care is available for complicated cases, medical abortion can be used safely even in the most rudimentary settings and provided by non-physician health workers. Given access to clinical assessment and counseling, some women can have the option of undergoing medical abortion outside of a clinical setting without direct medical supervision. Although the mifepristone-misoprostol regimen is most effective in women in the earliest durations of pregnancy, it has acceptable efficacy even after 57-63 days of amenorrhea. Medical abortion methods represent a critical advance in reproductive rights in countries where the consequences of unsafe abortion are most severe. If women are denied access to these methods, an unsafe "black market" for abortifacient agents may result.
Similar articles
-
Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.Contraception. 1999 Sep;60(3):167-72. doi: 10.1016/s0010-7824(99)00074-8. Contraception. 1999. PMID: 10640161
-
Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.Contraception. 1999 Jan;59(1):1-6. doi: 10.1016/s0010-7824(98)00150-4. Contraception. 1999. PMID: 10342079 Clinical Trial.
-
Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.Lancet. 1998 Aug 15;352(9127):542-3. doi: 10.1016/S0140-6736(05)79250-3. Lancet. 1998. PMID: 9716062
-
Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.Am J Obstet Gynecol. 2000 Aug;183(2 Suppl):S44-53. doi: 10.1067/mob.2000.107950. Am J Obstet Gynecol. 2000. PMID: 10944369 Review.
-
Current medical abortion care.Curr Womens Health Rep. 2003 Dec;3(6):461-9. Curr Womens Health Rep. 2003. PMID: 14613667 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials